articleThe LancetOct 30, 2017Closed access

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Icahn School of Medicine at Mount Sinai · University of Calgary · +19 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

908
total citations
FWCI
77.15
Percentile
100%
References
32
Citations per year

Authors

26

Topics & keywords

Keywords
  • Medicine
  • Adalimumab
  • Crohn's disease
  • Internal medicine
  • Prednisone
  • Azathioprine
  • Calprotectin
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding